2011 annual financial data

BioCryst Pharmaceuticals 2011 Net margin

BioCryst Pharmaceuticals 2011 net margin with verified reported values.

Direct answer

Net margin was -289.91%.

Operating income was -49,587,000 USD and net income was -56,948,000 USD.
Operating cash flow was -32,251,000 USD.

Get free BioCryst Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
19,643,000 USD
Operating income
-49,587,000 USD
Net income
-56,948,000 USD
Operating cash flow
-32,251,000 USD